Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics ...
5h
B. Riley Securities analyst Yuan Zhi initiated coverage on Radiopharm Theranostics Limited RADX with a Buy rating and ...
Fintel on MSN10h
BMO Capital Initiates Coverage of Avidity Biosciences (RNA) with Outperform RecommendationFintel reports that on March 12, 2025, BMO Capital initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Outperform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback